 | | DM8 | | 表記: | 2'-BROMO-4'-EPIDAUNORUBICIN | | 組成式: | C27 H28 Br N O10 | | SMILES: | O=C2c1c(O)c5c(c(O)c1C(=O)c3cccc(OC)c23)CC(O)(C(=O)C)CC5OC4OC(C(O)C(N)C4Br)C | | InChi: | InChI=1S/C27H28BrNO10/c1-9-21(31)20(29)19(28)26(38-9)39-14-8-27(36,10(2)30)7-12-16(14)25(35)18-17(23(12)33)22(32)11-5-4-6-13(37-3)15(11)24(18)34/h4-6,9,14,19-21,26,31,33,35-36H,7-8,29H2,1-3H3/t9-,14-,19+,20-,21-,26-,27-/m0/s1 | | 別名: | WP401 | | 定義日: | 1999-07-08 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | (1S,3S)-3-acetyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2-bromo-2,3,6-trideoxy-alpha-L-mannopyranoside |
|
 | | DMP | | 表記: | [4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-[1,3-BIS([4-HYDROXYMETHYL-PHENYL]METHYL)-4,7-BIS(PHEN
YLMETHYL)]-2H-1,3-DIAZEPINONE | | 組成式: | C35 H38 N2 O5 | | SMILES: | O=C1N(C(C(O)C(O)C(N1Cc2ccc(cc2)CO)Cc3ccccc3)Cc4ccccc4)Cc5ccc(cc5)CO | | InChi: | InChI=1S/C35H38N2O5/c38-23-29-15-11-27(12-16-29)21-36-31(19-25-7-3-1-4-8-25)33(40)34(41)32(20-26-9-5-2-6-10-26)37(35(36)42)22-28-13-17-30(24-39)18-14-28/h1-18,31-34,38-41H,19-24H2/t31-,32-,33+,34+/m1/s1 | | 別名: | DMP323(INHIBITOR OF DUPONT MERCK) | | 定義日: | 1999-07-08 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | (4R,5S,6S,7R)-4,7-dibenzyl-5,6-dihydroxy-1,3-bis[4-(hydroxymethyl)benzyl]-1,3-diazepan-2-one |
|
 | | 5H5 | | 表記: | (2S)-2-({2-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide | | 組成式: | C19 H22 N6 O3 | | SMILES: | C(=O)(C(C)Oc4ccc3c1n(cc(n1)c2n(C(C)C)ncn2)CCOc3c4)N | | InChi: | InChI=1S/C19H22N6O3/c1-11(2)25-19(21-10-22-25)15-9-24-6-7-27-16-8-13(28-12(3)17(20)26)4-5-14(16)18(24)23-15/h4-5,8-12H,6-7H2,1-3H3,(H2,20,26)/t12-/m0/s1 | | 別名: | GDC-0326 | | 定義日: | 2015-09-24 | | 最終更新日: | 2020-06-17 | | 公開日: | 2016-01-27 | | 識別子（ID）: | (2S)-2-({2-[1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl}oxy)propanamide |
|
 | | DMY | | 表記: | DISTAMYCIN A | | 組成式: | C22 H27 N9 O4 | | SMILES: | O=C(Nc1cc(C(=O)NCCC(=[N@H])N)n(c1)C)c3cc(NC(=O)c2cc(NC=O)cn2C)cn3C | | InChi: | InChI=1S/C22H27N9O4/c1-29-9-13(26-12-32)6-17(29)21(34)28-15-8-18(31(3)11-15)22(35)27-14-7-16(30(2)10-14)20(33)25-5-4-19(23)24/h6-12H,4-5H2,1-3H3,(H3,23,24)(H,25,33)(H,26,32)(H,27,35)(H,28,34) | | 別名: | DISTAMYCIN | | 定義日: | 1999-07-08 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | N-[5-({5-[(3-amino-3-iminopropyl)carbamoyl]-1-methyl-1H-pyrrol-3-yl}carbamoyl)-1-methyl-1H-pyrrol-3-yl]-4-(formylamino)-1-methyl-1H-pyrrole-2-carboxamide |
|
 | | DN1 | | 表記: | 3-({(2S)-2-[({(1R)-1-[({(1R)-1-[(R)-CARBOXY(HYDROXY)METHYL]-3,3-DIFLUOROPROPYL}AMINO)CARBONYL]-3-METHYLBUTYL}AMINO)CARB
ONYL]-2,3-DIHYDRO-1H-INDOL-2-YL}METHYL)THIOPHENE-2-CARBOXYLIC ACID | | 組成式: | C26 H31 F2 N3 O7 S | | SMILES: | O=C(O)C(O)C(NC(=O)C(NC(=O)C2(Nc1ccccc1C2)Cc3c(scc3)C(=O)O)CC(C)C)CC(F)F | | InChi: | InChI=1S/C26H31F2N3O7S/c1-13(2)9-18(22(33)29-17(10-19(27)28)20(32)23(34)35)30-25(38)26(11-14-5-3-4-6-16(14)31-26)12-15-7-8-39-21(15)24(36)37/h3-8,13,17-20,31-32H,9-12H2,1-2H3,(H,29,33)(H,30,38)(H,34,35)(H,36,37)/t17-,18-,20-,26+/m1/s1 | | 別名: | PEPTIDOMIMETIC INHIBITOR | | 定義日: | 2004-07-14 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 3-{[N-({(2S)-2-[(2-carboxythiophen-3-yl)methyl]-2,3-dihydro-1H-indol-2-yl}carbonyl)-D-leucyl]amino}-3,4,5-trideoxy-5,5-difluoro-D-erythro-pentonic acid |
|
 | | DN4 | | 表記: | [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl]
[(2R,3S,4R,5R)-5-(3-carboxypyridin-1-ium-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl phosphate | | 組成式: | C21 H27 N6 O18 P3 | | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CO[P](O)(=O)O[P]([O-])(=O)OC[CH]4O[CH]([CH](O)[CH]4O)[n+]5cccc(c5)C(O)=O)[CH](O)[CH]3O[P](O)(O)=O | | InChi: | InChI=1S/C21H27N6O18P3/c22-17-12-18(24-7-23-17)27(8-25-12)20-16(44-46(33,34)35)14(29)11(43-20)6-41-48(38,39)45-47(36,37)40-5-10-13(28)15(30)19(42-10)26-3-1-2-9(4-26)21(31)32/h1-4,7-8,10-11,13-16,19-20,28-30H,5-6H2,(H6-,22,23,24,31,32,33,34,35,36,37,38,39)/t10-,11-,13-,14-,15-,16-,19-,20-/m1/s1 | | 別名: | Nicotinic acid adenine dinucleotide phosphate | | 定義日: | 2012-05-24 | | 最終更新日: | 2020-06-17 | | 公開日: | 2013-04-03 | | 識別子（ID）: | [[(2R,3R,4R,5R)-5-(6-aminopurin-9-yl)-3-oxidanyl-4-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(2R,3S,4R,5R)-5-(3-carboxypyridin-1-ium-1-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methyl phosphate |
|
 | | 5HM | | 表記: | 5-(hydroxymethyl)cytidine 5'-(dihydrogen phosphate) | | 組成式: | C10 H16 N3 O9 P | | SMILES: | O=P(O)(O)OCC2OC(N1C(=O)N=C(N)C(=C1)CO)C(O)C2O | | InChi: | InChI=1S/C10H16N3O9P/c11-8-4(2-14)1-13(10(17)12-8)9-7(16)6(15)5(22-9)3-21-23(18,19)20/h1,5-7,9,14-16H,2-3H2,(H2,11,12,17)(H2,18,19,20)/t5-,6-,7-,9-/m1/s1 | | 別名: | 5-hydroxymethylcytidine 5'-monophosphate | | 定義日: | 2014-01-22 | | 最終更新日: | 2020-06-17 | | 公開日: | 2014-06-25 | | 識別子（ID）: | 5-(hydroxymethyl)cytidine 5'-(dihydrogen phosphate) |
|
 | | 5HN | | 表記: | 5-hydroxypyridine-3-carboxylic acid | | 組成式: | C6 H5 N O3 | | SMILES: | O=C(O)c1cncc(O)c1 | | InChi: | InChI=1S/C6H5NO3/c8-5-1-4(6(9)10)2-7-3-5/h1-3,8H,(H,9,10) | | 別名: | 5-Hydroxynicotinic Acid | | 定義日: | 2012-10-01 | | 最終更新日: | 2020-06-17 | | 公開日: | 2013-09-18 | | 識別子（ID）: | 5-hydroxypyridine-3-carboxylic acid |
|
 | | DNA | | 表記: | 1,4-dihydroxy-2-naphthoic acid | | 組成式: | C11 H8 O4 | | SMILES: | O=C(O)c2cc(O)c1ccccc1c2O | | InChi: | InChI=1S/C11H8O4/c12-9-5-8(11(14)15)10(13)7-4-2-1-3-6(7)9/h1-5,12-13H,(H,14,15) | | 別名: | 1,4-dihydroxynaphthalene-2-carboxylic acid | | 定義日: | 2009-07-10 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 1,4-dihydroxynaphthalene-2-carboxylic acid |
|
 | | DND | | 表記: | NICOTINIC ACID ADENINE DINUCLEOTIDE | | 組成式: | C21 H27 N6 O15 P2 | | SMILES: | Nc1ncnc2n(cnc12)[CH]3O[CH](CO[P](O)(=O)O[P](O)(=O)OC[CH]4O[CH]([CH](O)[CH]4O)[n+]5cccc(c5)C(O)=O)[CH](O)[CH]3O | | InChi: | InChI=1S/C21H26N6O15P2/c22-17-12-18(24-7-23-17)27(8-25-12)20-16(31)14(29)11(41-20)6-39-44(36,37)42-43(34,35)38-5-10-13(28)15(30)19(40-10)26-3-1-2-9(4-26)21(32)33/h1-4,7-8,10-11,13-16,19-20,28-31H,5-6H2,(H4-,22,23,24,32,33,34,35,36,37)/p+1/t10-,11-,13-,14-,15-,16-,19-,20-/m1/s1 | | 別名: | DEAMIDO-NAD+ | | 定義日: | 2001-04-16 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 1-[(2R,3R,4S,5R)-5-[[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]oxy-oxidanyl-phosphoryl]oxymethyl]-3,4-bis(oxidanyl)oxolan-2-yl]pyridin-1-ium-3-carboxylic acid |
|
 | | 5HV | | 表記: | N-[2-(diethylamino)ethyl]-2-{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}-N-{[
4'-(trifluoromethyl)biphenyl-4-yl]methyl}acetamide | | 組成式: | C36 H38 F4 N4 O2 S | | SMILES: | CCN(CC)CCN(Cc2ccc(c1ccc(C(F)(F)F)cc1)cc2)C(=O)CN3C(=NC(C4=C3CCC4)=O)SCc5ccc(cc5)F | | InChi: | InChI=1S/C36H38F4N4O2S/c1-3-42(4-2)20-21-43(22-25-8-12-27(13-9-25)28-14-16-29(17-15-28)36(38,39)40)33(45)23-44-32-7-5-6-31(32)34(46)41-35(44)47-24-26-10-18-30(37)19-11-26/h8-19H,3-7,20-24H2,1-2H3 | | 別名: | Darapladib | | 定義日: | 2015-09-28 | | 最終更新日: | 2020-06-17 | | 公開日: | 2016-06-15 | | 識別子（ID）: | N-[2-(diethylamino)ethyl]-2-{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}-N-{[4'-(trifluoromethyl)biphenyl-4-yl]methyl}acetamide |
|
 | | DNL | | 表記: | 6-AMINO-HEXANAL | | 組成式: | C6 H13 N O | | SMILES: | O=CCCCCCN | | InChi: | InChI=1S/C6H13NO/c7-5-3-1-2-4-6-8/h6H,1-5,7H2 | | 別名: | ALPHA-DEAMINO-LYSINAL | | 定義日: | 2001-09-05 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 6-aminohexanal |
|
 | | 5I5 | | 表記: | 7-(5-DEOXY-BETA-D-RIBOFURANOSYL)-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE | | 組成式: | C11 H13 I N4 O3 | | SMILES: | Ic2c1c(ncnc1n(c2)C3OC(C(O)C3O)C)N | | InChi: | InChI=1S/C11H13IN4O3/c1-4-7(17)8(18)11(19-4)16-2-5(12)6-9(13)14-3-15-10(6)16/h2-4,7-8,11,17-18H,1H3,(H2,13,14,15)/t4-,7-,8-,11-/m1/s1 | | 別名: | 5'-DEOXY-5-IODOTUBERCIDIN | | 定義日: | 2006-10-20 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 7-(5-deoxy-beta-D-ribofuranosyl)-5-iodo-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
|
 | | DNS | | 表記: | N~6~-{[5-(DIMETHYLAMINO)-1-NAPHTHYL]SULFONYL}-L-LYSINE | | 組成式: | C18 H25 N3 O4 S | | SMILES: | O=C(O)C(N)CCCCNS(=O)(=O)c1cccc2c1cccc2N(C)C | | InChi: | InChI=1S/C18H25N3O4S/c1-21(2)16-10-5-8-14-13(16)7-6-11-17(14)26(24,25)20-12-4-3-9-15(19)18(22)23/h5-8,10-11,15,20H,3-4,9,12,19H2,1-2H3,(H,22,23)/t15-/m0/s1 | | 別名: | DANSYLLYSINE | | 定義日: | 2005-02-22 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | N~6~-{[5-(dimethylamino)naphthalen-1-yl]sulfonyl}-L-lysine |
|
 | | 5ID | | 表記: | (2R,3R,4S,5R)-2-(4-AMINO-5-IODO-7H-PYRROLO[2,3-D]PYRIMIDIN-7-YL)-5-(HYDROXYMETHYL)TETRAHYDROFURAN-3,4-DIOL | | 組成式: | C11 H13 I N4 O4 | | SMILES: | Ic2c1c(ncnc1n(c2)C3OC(C(O)C3O)CO)N | | InChi: | InChI=1S/C11H13IN4O4/c12-4-1-16(10-6(4)9(13)14-3-15-10)11-8(19)7(18)5(2-17)20-11/h1,3,5,7-8,11,17-19H,2H2,(H2,13,14,15)/t5-,7-,8-,11-/m1/s1 | | 別名: | 5-IODOTUBERCIDIN | | 定義日: | 2005-10-16 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 5-iodo-7-beta-D-ribofuranosyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine |
|
 | | DOG | | 表記: | DIGOXIGENIN | | 組成式: | C23 H34 O5 | | SMILES: | O=C1OCC(=C1)C5C4(C(O)CC3C(CCC2CC(O)CCC23C)C4(O)CC5)C | | InChi: | InChI=1S/C23H34O5/c1-21-7-5-15(24)10-14(21)3-4-17-18(21)11-19(25)22(2)16(6-8-23(17,22)27)13-9-20(26)28-12-13/h9,14-19,24-25,27H,3-8,10-12H2,1-2H3/t14-,15+,16-,17-,18+,19-,21+,22+,23+/m1/s1 | | 別名: | 4-(3,12,14-TRIHYDROXY-10,13-DIMETHYL-HEXADECAHYDRO-CYCLOPENTA[A]PHENANTHREN-17-YL)-5H-FURAN-2-ONE | | 定義日: | 2002-05-06 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | (3alpha,5beta,8alpha,12beta)-3,12,14-trihydroxycard-20(22)-enolide |
|
 | | DON | | 表記: | 6-DIAZENYL-5-OXO-L-NORLEUCINE | | 組成式: | C6 H11 N3 O3 | | SMILES: | O=C(O)C(N)CCC(=O)CN=[N@H] | | InChi: | InChI=1S/C6H11N3O3/c7-5(6(11)12)2-1-4(10)3-9-8/h5,8H,1-3,7H2,(H,11,12)/t5-/m0/s1 | | 別名: | (S)-2-AMINO-6-DIAZENYL-5-OXOHEXANOIC ACID | | 定義日: | 2007-02-08 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 6-diazenyl-5-oxo-L-norleucine |
|
 | | DOQ | | 表記: | (2S,3S,4S)-2-CARBOXY-4-[(1Z,3E,5R)-5-CARBOXY-1-METHYL-1,3-HEXADIENYL]-3-PYRROLIDINEACETIC ACID | | 組成式: | C15 H21 N O6 | | SMILES: | O=C(O)C(/C=C/C=C(C1C(C(C(=O)O)NC1)CC(=O)O)C)C | | InChi: | InChI=1S/C15H21NO6/c1-8(4-3-5-9(2)14(19)20)11-7-16-13(15(21)22)10(11)6-12(17)18/h3-5,9-11,13,16H,6-7H2,1-2H3,(H,17,18)(H,19,20)(H,21,22)/b5-3+,8-4-/t9-,10+,11-,13+/m1/s1 | | 別名: | (2S,3S,4S)-3-CARBOXYMETHYL-4-[(1Z,3E,5R)-5-CARBOXY-1-METHYL-HEXA-1,3-DIENYL]-PYRROLIDINE-2-CARBOXYLIC ACID | | 定義日: | 2005-01-14 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | (3S,4S)-3-(carboxymethyl)-4-[(1Z,3E,5R)-5-carboxy-1-methylhexa-1,3-dien-1-yl]-L-proline |
|
 | | 5J6 | | 表記: | methyl 4-(2-bromo-4-fluorophenyl)-6-(morpholin-4-ylmethyl)-2-(1,3-thiazol-2-yl)pyrimidine-5-carboxylate | | 組成式: | C20 H18 Br F N4 O3 S | | SMILES: | Fc1cc(Br)c(cc1)c3nc(c2sccn2)nc(c3C(OC)=O)CN4CCOCC4 | | InChi: | InChI=1S/C20H18BrFN4O3S/c1-28-20(27)16-15(11-26-5-7-29-8-6-26)24-18(19-23-4-9-30-19)25-17(16)13-3-2-12(22)10-14(13)21/h2-4,9-10H,5-8,11H2,1H3 | | 別名: | NVR10-001E2 | | 定義日: | 2015-09-29 | | 最終更新日: | 2020-06-17 | | 公開日: | 2015-12-09 | | 識別子（ID）: | methyl 4-(2-bromo-4-fluorophenyl)-6-(morpholin-4-ylmethyl)-2-(1,3-thiazol-2-yl)pyrimidine-5-carboxylate |
|
 | | DPB | | 表記: | (S)-1-[2'-DEOXY-3',5'-O-(1-PHOSPHONO)BENZYLIDENE-B-D-THREO-PENTOFURANOSYL]THYMINE | | 組成式: | C17 H19 N2 O8 P | | SMILES: | O=C1C(=CN(C(=O)N1)C4OC2C(OC(OC2)(c3ccccc3)P(=O)(O)O)C4)C | | InChi: | InChI=1S/C17H19N2O8P/c1-10-8-19(16(21)18-15(10)20)14-7-12-13(26-14)9-25-17(27-12,28(22,23)24)11-5-3-2-4-6-11/h2-6,8,12-14H,7,9H2,1H3,(H,18,20,21)(H2,22,23,24)/t12-,13-,14-,17-/m0/s1 | | 別名: | DPB-T | | 定義日: | 2003-09-17 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 1-{2-deoxy-3,5-O-[phenyl(phosphono)methylidene]-beta-L-threo-pentofuranosyl}-5-methylpyrimidine-2,4(1H,3H)-dione |
|
 | | DPK | | 表記: | DEPRENYL | | 組成式: | C13 H19 N | | SMILES: | N(C(Cc1ccccc1)C)(CC=C)C | | InChi: | InChI=1S/C13H19N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h4-9,12H,1,10-11H2,2-3H3/t12-/m1/s1 | | 別名: | N-METHYL-N-[(1R)-1-METHYL-2-PHENYLETHYL]PROP-2-EN-1-AMINE | | 定義日: | 2005-07-29 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | N-methyl-N-[(1R)-1-methyl-2-phenylethyl]prop-2-en-1-amine |
|
 | | DQT | | 表記: | methyl 3-deoxy-2-O-(4-methylbenzoyl)-3-[(4-methylbenzoyl)amino]-beta-D-talopyranoside | | 組成式: | C23 H27 N O7 | | SMILES: | O=C(c1ccc(cc1)C)NC3C(O)C(OC(OC)C3OC(=O)c2ccc(cc2)C)CO | | InChi: | InChI=1S/C23H27NO7/c1-13-4-8-15(9-5-13)21(27)24-18-19(26)17(12-25)30-23(29-3)20(18)31-22(28)16-10-6-14(2)7-11-16/h4-11,17-20,23,25-26H,12H2,1-3H3,(H,24,27)/t17-,18+,19+,20+,23-/m1/s1 | | 別名: | methyl 3-deoxy-2-O-4-toluoyl-3-(4-toluoyl)amino-beta-D-talopyranoside | | 定義日: | 2011-08-31 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | methyl 3-deoxy-2-O-(4-methylbenzoyl)-3-[(4-methylbenzoyl)amino]-beta-D-talopyranoside |
|
 | | DR1 | | 表記: | 5-METHYL-5H-INDOLO[3,2-B]QUINOLINE | | 組成式: | C16 H12 N2 | | SMILES: | N2=C1C(C=CC=C1)=C4C2=Cc3ccccc3N4C | | InChi: | InChI=1S/C16H12N2/c1-18-15-9-5-2-6-11(15)10-14-16(18)12-7-3-4-8-13(12)17-14/h2-10H,1H3 | | 別名: | CRYPTOLEPINE | | 定義日: | 2001-11-02 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | 5-methyl-5H-indolo[3,2-b]quinoline |
|
 | | DR4 | | 表記: | METHYL 9-(BETA-D-TALOPYRANOSYLOXY)NONANOATE | | 組成式: | C16 H30 O8 | | SMILES: | O=C(OC)CCCCCCCCOC1OC(C(O)C(O)C1O)CO | | InChi: | InChI=1S/C16H30O8/c1-22-12(18)8-6-4-2-3-5-7-9-23-16-15(21)14(20)13(19)11(10-17)24-16/h11,13-17,19-21H,2-10H2,1H3/t11-,13+,14+,15-,16-/m1/s1 | | 別名: | GALACTOSE GREASE | | 定義日: | 2005-05-13 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | methyl 9-(beta-D-galactopyranosyloxy)nonanoate |
|
 | | DR7 | | 表記: | (3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5,
6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER | | 組成式: | C38 H52 N6 O7 | | SMILES: | O=C(OC)NC(C(=O)NC(Cc1ccccc1)C(O)CN(NC(=O)C(NC(=O)OC)C(C)(C)C)Cc3ccc(c2ncccc2)cc3)C(C)(C)C | | InChi: | InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1 | | 別名: | ATAZANAVIR | | 定義日: | 2005-09-26 | | 最終更新日: | 2020-06-17 | | 識別子（ID）: | methyl [(1S,4S,5S,10S)-4-benzyl-1,10-di-tert-butyl-5-hydroxy-2,9,12-trioxo-7-(4-pyridin-2-ylbenzyl)-13-oxa-3,7,8,11-tetraazatetradec-1-yl]carbamate (non-preferred name) |
|
